Bellus Health

+$0.65 (+8.52%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Bellus Health and other ETFs, options, and stocks.

About BLU

BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch.

CEO
Roberto Bellini
Employees
40
Headquarters
Laval, Québec
Founded
1993

BLU Key Statistics

Market cap
884.41M
Price-Earnings ratio
—
Dividend yield
—
Average volume
656.56K
High today
$8.42
Low today
$7.57
Open price
$7.62
Volume
601.23K
52 Week high
$9.84
52 Week low
$2.60

BLU Earnings

-$0.29
-$0.19
-$0.10
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure